dataFormula C25H28N6OMol. mass 428.53SMILES eMolecules & PubChemPharmacokinetic dataBioavailability 60–80%Metabolism Hepatic (CYP2C9)Half life 11–15 side effects of avapro 150 mg. Renal 20%, faecal 65%Therapeutic considerationsLicence data EU, USPregnancy cat. D (Au)Legal status S4 (Au), POM (UK), ?-only.

dataFormula C25H28N6OMol. mass 428.53SMILES eMolecules & PubChemPharmacokinetic dataBioavailability 60–80%Metabolism side effects of avapro 150 mg. (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic considerationsLicence data EU, USPregnancy cat. side effects of avapro 150 mg. (Au)Legal status S4 (Au), POM (UK), side effects of avapro 150 mg. (U.S.)Routes OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is an angiotensin II receptor side effects of avapro 150 mg. irbesartan is indicated for the side effects of avapro 150 mg. of hypertension. Irbesartan was developed by Sanofi Research (now side effects of avapro 150 mg. of side effects of avapro 150 mg. It is jointly marketed by sanofi-aventis and Bristol-Myers Squibb under the trade names Aprovel, Karvea, and Avapro.Contents [hide]1 Clinical use1.1 Indications1.2 Combination with diuretic2 References3 See also[edit] Clinical useMain article: Angiotensin II receptor antagonists, irbesartan is indicated for the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by sanofi-aventis and.

dataFormula C25H28N6OMol. mass 428.53SMILES eMolecules & PubChemPharmacokinetic.